Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Occult Hepatitis B Virus Infection and S Gene Escape Mutants in Hiv-Infected Patients After Hepatitis B Virus Vaccination Publisher Pubmed



Aghakhani A1 ; Mohraz M2 ; Aghasadeghi MR3 ; Banifazl M4 ; Vahabpour R3 ; Karami A5 ; Foroughi M2 ; Ramezani A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran
  2. 2. Iranian Research Center for HIV/AIDS, Tehran, Iran
  3. 3. Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran
  4. 4. Iranian Society for Support of Patients with Infectious Diseases, Tehran, Iran
  5. 5. Zanjan University of Medical Sciences, Zanjan, Iran

Source: International Journal of STD and AIDS Published:2016


Abstract

Hepatitis B virus (HBV) vaccination is recommended for HIV patients. Despite the relative success of HBV vaccination, breakthrough infections can occur infrequently in patients, and it can be due to occult HBV infection, vaccine unresponsiveness and/or emergence of escape mutants. This study assessed the presence of occult HBV infection and S gene escape mutants in HIV-positive patients after HBV vaccination. Ninety-two HIV-positive patients were enrolled in this study, including 52 responders to HBV vaccine and 40 non-responders. All of the cases received HBV vaccine according to routine HBV vaccination protocols. The presence of HBV-DNA was determined by real-time polymerase chain reaction (PCR). In HBV-DNA positive samples, the most conserved regions of S gene sequences were amplified by nested PCR and PCR products were sequenced. Occult HBV infection was detected in two cases. Glycine to arginine mutation at residue 145 (G145R) within the ‘a’ region of the S gene was detected in one of the occult HBV infection cases who was in the non-responder group. This study showed that the prevalence of occult HBV infection and vaccine escape mutants was low in our HBV-vaccinated HIV-positive patients in both responder and non-responder groups, so there was no alarming evidence indicating breakthrough HBV infection in our vaccinated HIV-positive cases. © 2016, © The Author(s) 2016.